Want to join the conversation?
Biotechnology company $AMGN said the European Commission (EC) has approved the marketing authorization for Kyprolis to include use in combination with dexamethasone for adults with multiple myeloma, an incurable blood cancer, who have received at least one prior therapy.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)